Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Global Ostomy Care Market Outlook & Forecast Report 2022-2027 - The Emergence of Next -Generation Ostomy Care & High Demand for Home Healthcare Agencies Among Ostomates


DUBLIN, Jan. 28, 2022 /PRNewswire/ -- The "Ostomy Care Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The ostomy care market by revenue is expected to grow at a CAGR of 4% during the period 2022-2027.

The report considers the present scenario of the ostomy care market and its market dynamics for the period 2022-2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyses leading companies and several other prominent companies operating in the market.

Ostomy care products are designed to enhance and improve patients' quality of life who undergo ostomy surgery. Many key players and regional players are offering a wide range of bags and accessories for the management of ostomy thereby, contributing to the growth of the ostomy care market.

SEGMENTATION ANALYSIS

The ostomy bags segment to retain its market dominance during the forecast period. Ostomy bags are also called ostomy pockets or ostomy machines. They come in three distinct sorts and with various alternatives which are benefiting the market globally.

Continent ileostomy and continent urostomy bags are other popular segments due to the occurrence of conditions such as incontinence and rise in obesity and individuals prone to diabetes.

GEOGRAPHICAL ANALYSIS

Germany is the major revenue generator in the European market. The country is experiencing healthy growth due to the increasing demand for ostomy pouches, accessories, and services at a rapid rate.

French health care system is one of the best services of public health care in the world. The health care system in France is made up of a fully integrated network of public and private hospitals, doctors, and other medical service providers.

VENDOR ANALYSIS

Key players are dominating the global market with substantially greater financial, manufacturing, marketing, and technical resources that enable well-established brands, widespread distribution channels, broader product offerings, and an established customer base.

Coloplast is the market leader with a dominant share in the global ostomy care market. The Coloplast's main revenue driver products are SenSura Mio and the Brava range of supporting products. There is a massive pool of many mid-sized and emerging vendors contributing to the growth of the market.

SNIPPETS

KEY GROWTH FACTORS

Prominent Vendors

Other Prominent Vendors

Key Topics Covered:

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope Of The Study

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 Market at a Glance

7 Introduction
7.1 Overview
7.1.1 Reasons For Stoma Surgery
7.1.2 Types Of Stoma Surgery
7.1.3 Surgery
7.1.4 Complications
7.2 Ostomy Care: Market Snapshot
7.2.1 Overview

8 Market Opportunities & Trends
8.1 Emergence Of Next-Generation Ostomy Care
8.2 High Demand For Home Healthcare Agencies Among Ostomates
8.3 High Growth Potential Of Ostomy Care In Emerging Markets
8.4 Increasing Adoption Of Telehealth For Ostomy Care

9 Market Growth Enablers
9.1 Prevalance Of Diseases Resulting In Ostomy Surgeries
9.2 Favorable Reimbursement Policies In Developed Countries
9.3 Advanced Technology Ostomy Care Products

10 Market Restraints
10.1 Complications Related To Ostomy Care Products
10.2 Lack Of Awareness And Knowledge Gap Among Ostomy Patients
10.3 Emotional And Psychological Impact On Ostomy Patients

11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.2.1 Geography
11.2.2 Products
11.2.3 Systems
11.2.4 Usage
11.2.5 Shape
11.2.6 End-User
11.3 Impact Of Covid-19 On The Ostomy Care Market
11.4 FIVE FORCES ANALYSIS

12 Products
12.1 Market Snapshot & Growth Engine
12.2 Market Overview

13 Ostomy Bags
13.1 Market Overview
13.2 Market Size & Forecast
13.3 Ostomy Bags: Geography
13.4 Surgery
13.4.1 Colostomy Surgery Bags: Market Size & Forecast
13.4.2 Ileostomy Surgery Bag: Market Size & Forecast
13.4.3 Urostomy Surgery Bag: Market Size & Forecast

14 Ostomy Accessories
14.1 Market Overview
14.2 Market Size & Forecast
14.3 Ostomy Accessories: Geography

15 Systems
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 One-Piece Systems
15.4 Two-Piece Systems

16 Usage
16.1 Market Snapshot & Growth Engine
16.2 Market Overview
16.3 Drainable Ostomy Care Products
16.4 Closed-End Ostomy Care Products

17 Shape
17.1 Market Snapshot & Growth Engine
17.2 Market Overview
17.3 Flat Ostomy Care Products
17.4 Convex Ostomy Care Products

18 End-User
18.1 Market Snapshot & Growth Engine
18.2 Market Overview
18.3 Hospitals
18.4 Post-Acute Care Centers
18.5 Home Care

19 Geography
19.1 Market Snapshot & Growth Engine
19.2 Geographic Overview

For more information about this report visit https://www.researchandmarkets.com/r/gvimf5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 06:05
The 2023 U.S. soybean field trials conducted by Texas Crop Science (TCS) demonstrated an average yield increase of 21% in soybean lines incorporating the TCS yield trait. This breakthrough in performance would generate approximately $121 per acre in...

at 06:05
3EO Health, a "Point of Life" diagnostics company focused on the development of high-performing low-cost molecular diagnostics, is excited to announce the next step in their quest to make molecular testing affordable. Today, the company has published...

at 06:05
Zura Bio Limited ("Zura Bio") a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today reported full year 2023 financial results and recent business highlights. The Company has also...

at 06:00
Zymeworks Inc. , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced the appointment of Dr. Neil Gallagher to...

at 06:00
...

at 06:00
The "Licensing Deals in Biotechnology 2019-2024" report has been added to  ResearchAndMarkets.com's offering. Licensing Deals in Biotechnology provides a detailed understanding and analysis of how and why companies enter licensing deals. Fully...



News published on and distributed by: